400 related articles for article (PubMed ID: 35213007)
1. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
Gait MJ; Agrawal S
Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
[TBL] [Abstract][Full Text] [Related]
2. Challenges and Opportunities for Nucleic Acid Therapeutics.
Corey DR; Damha MJ; Manoharan M
Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
[TBL] [Abstract][Full Text] [Related]
3. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
5. Stereocontrolled Oligonucleotides for Nucleic Acid Therapeutics: A Perspective.
Meena ; Lemaitre MM
Nucleic Acid Ther; 2021 Feb; 31(1):1-6. PubMed ID: 33305971
[No Abstract] [Full Text] [Related]
6. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Oligonucleotides: State of the Art.
Smith CIE; Zain R
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():605-630. PubMed ID: 30285540
[TBL] [Abstract][Full Text] [Related]
8. [Recent progress and prospect in oligonucleotide therapeutics].
Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.
Grünweller A; Wyszko E; Bieber B; Jahnel R; Erdmann VA; Kurreck J
Nucleic Acids Res; 2003 Jun; 31(12):3185-93. PubMed ID: 12799446
[TBL] [Abstract][Full Text] [Related]
10. Sugar boost: when ribose modifications improve oligonucleotide performance.
Faria M; Ulrich H
Curr Opin Mol Ther; 2008 Apr; 10(2):168-75. PubMed ID: 18386229
[TBL] [Abstract][Full Text] [Related]
11. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
Vetter VC; Wagner E
J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
[TBL] [Abstract][Full Text] [Related]
12. Advancing Nucleic Acid Therapeutics by Setting Uniform Standards for Experimental Controls.
Aartsma-Rus A; Krieg AM
Nucleic Acid Ther; 2019 Jun; 29(3):115. PubMed ID: 30964415
[No Abstract] [Full Text] [Related]
13. Oligomeric nucleic acids as antivirals.
Mescalchin A; Restle T
Molecules; 2011 Jan; 16(2):1271-96. PubMed ID: 21278679
[TBL] [Abstract][Full Text] [Related]
14. Biological applications of xeno nucleic acids.
Morihiro K; Kasahara Y; Obika S
Mol Biosyst; 2017 Jan; 13(2):235-245. PubMed ID: 27827481
[TBL] [Abstract][Full Text] [Related]
15. Prospects for nucleic acid-based therapeutics against hepatitis C virus.
Lee CH; Kim JH; Lee SW
World J Gastroenterol; 2013 Dec; 19(47):8949-62. PubMed ID: 24379620
[TBL] [Abstract][Full Text] [Related]
16. Post-transcriptional gene silencing by nucleic acid gapmers: a promising therapeutic modality for cancer.
Priyadharsini JV; Arumugam P
Epigenomics; 2023 Jan; 15(2):53-56. PubMed ID: 36802730
[No Abstract] [Full Text] [Related]
17. Nucleic acid-based therapeutics for dermal wound healing.
Sharma P; Kumar A; Agarwal T; Dey AD; Moghaddam FD; Rahimmanesh I; Ghovvati M; Yousefiasl S; Borzacchiello A; Mohammadi A; Yella VR; Moradi O; Sharifi E
Int J Biol Macromol; 2022 Nov; 220():920-933. PubMed ID: 35987365
[TBL] [Abstract][Full Text] [Related]
18. The current landscape of nucleic acid therapeutics.
Kulkarni JA; Witzigmann D; Thomson SB; Chen S; Leavitt BR; Cullis PR; van der Meel R
Nat Nanotechnol; 2021 Jun; 16(6):630-643. PubMed ID: 34059811
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acids-based therapeutics in the battle against pathogenic viruses.
Haasnoot J; Berkhout B
Handb Exp Pharmacol; 2009; 189(189):243-63. PubMed ID: 19048203
[TBL] [Abstract][Full Text] [Related]
20. Progress on RNA-based therapeutics for genetic diseases.
Luo T; Huo C; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
